HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Interobserver agreement in the assessment of components of colposcopic grading.

AbstractOBJECTIVE:
To estimate the reproducibility of the assessment of visual characteristics of cervical lesions used to judge lesion grade from colposcopy.
METHODS:
Digitized cervical images from 862 women enrolled in the ASCUS-LSIL Triage Study were obtained after application of 5% acetic acid. Each image was later assessed online by two randomly assigned evaluators from a pool of 20 experienced colposcopists. Interobserver agreement beyond chance was assessed by kappa statistics.
RESULTS:
Of 862 evaluable images with paired assessments, 607 were considered to have an acetowhite lesion by both evaluators, 171 by one, and 84 by neither. Kappa values (95% confidence intervals) for agreement were 0.22 (0.17-0.27) for color, 0.24 (0.18-0.30) for margins, 0.22 (0.16-0.29) for mosaicism, 0.17 (0.11-0.23) for punctation, 0.11 (0.00-0.22) for atypical vessels, and 0.26 (0.22-0.31) for modified Reid Index score.
CONCLUSION:
Characteristics used to assign colposcopic grade are poorly reproducible when used to assess static cervical images from women with borderline cytology results.
LEVEL OF EVIDENCE:
II.
AuthorsL Stewart Massad, Jose Jeronimo, Mark Schiffman, National Institutes of Health/American Society for Colposcopy and Cervical Pathology (NIH/ASCCP) Research Group
JournalObstetrics and gynecology (Obstet Gynecol) Vol. 111 Issue 6 Pg. 1279-84 (Jun 2008) ISSN: 0029-7844 [Print] United States
PMID18515509 (Publication Type: Journal Article)
Topics
  • Colposcopy (standards)
  • Female
  • Humans
  • Observer Variation
  • Random Allocation
  • Uterine Cervical Neoplasms (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: